“…With internal control disclosures, studies have examined the determinants of internal control weaknesses (e.g., Ashbaugh-Skaife, Collins, & Kinney, 2007;Doyle, Ge, & McVay, 2007b), the association between internal control effectiveness and the quality of accruals (e.g., Ashbaugh-Skaife et al, 2008;Chan et al, 2008;Doyle et al, 2007a), market reactions to the disclosures of internal control weaknesses (e.g., Hammersley, Myers, & Shakespeare, 2008), the association between internal control quality and cost of capital (e.g., Ashbaugh-Skaife, Collins, Kinney, & LaFond, 2009;Beneish, Billings, & Hodder, 2008;Costello & Wittenberg-Moerman, 2011;Gordon & Wilford, 2012;Ogneva, Subramanyam, & Raghunandan, 2007), the effect of internal control weaknesses on audit risk and audit fees (e.g., Ettredge, Li, & Sun, 2006;Raghunandan & Rama, 2006), the relation between internal control quality and the accuracy of management earnings guidance (e.g., Feng, Li, & McVay, 2009), and the effect of material weaknesses on shareholders' decision to withhold votes on director re-election (Ye, Hermanson, & Krishnan, 2013). However, there is limited evidence on the consequences of internal control evaluation and disclosure as required by Section 404 of SOX for firms' real decisions (e.g., firm investment).…”